Impact of specific mutant KRAS on clinical outcome of EGFR-TKI-treated advanced non-small cell lung cancer patients with an EGFR wild type genotypeGiulio Metro, Lucio Crinò, Simona Duranti et al.|Lung Cancer|2012Cited by 70